Announcements

Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., filed an amended and restated free writing prospectus on November 5, 2026, offering 5-year buffer securities linked to the S&P 500 Futures Excess Return Index (ticker: SPXFP), with a pricing date of November 30, 2026, …

Citigroup Global Markets Holdings Inc. filed a free writing prospectus on November 5, 2026, disclosing terms for Contingent Income Auto-Callable Securities due November 16, 2029, linked to the common stock of NVIDIA Corporation.

Citigroup Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, disclosing operational results, segment changes, and capital information for the period.

SkinHealth Systems Inc. filed a Form 8-K with the SEC on November 5, 2026, announcing its financial results for the fiscal quarter ended September 30, 2026, alongside an accompanying press release and conference call.

SkinHealth Systems Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting a net loss of $888 thousand for the third quarter.

Solventum Corporation filed its Form 10-Q with the Securities and Exchange Commission on November 5, 2026, covering the quarterly period ended September 30, 2026, disclosing a net loss of $12 million on total net sales of $1.949 billion for the third quarter.

Hyperliquid Strategies Inc. filed a Form 8-K on November 5, 2026, reporting voting results from its annual stockholder meeting held November 4, 2026, the election of two directors to three-year terms, approval of a Nasdaq share-issuance proposal, and ratification of its independent auditor, alongside …